Managment of functioning thyroid cancer.
D000230:Adenocarcinoma / Q000628:therapy; D000328:Adult; D000368:Aged; D001706:Biopsy; D004064:Digestive System / Q000503:physiopathology; D005260:Female; D006258:Head and Neck Neoplasms; D006760:Hospitalization; D006801:Humans; D007456:Iodine Isotopes / Q000627:therapeutic use; D008198:Lymph Nodes / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D011877:Radionuclide Imaging; D012469:Salivary Glands / Q000503:physiopathology; D013899:Thoracic Neoplasms; D013960:Thyroid Function Tests; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use; D013997:Time Factors; D014284:Triiodothyronine / Q000627:therapeutic use
D007456:Iodine Isotopes; D014284:Triiodothyronine; D013974:Thyroxine